Bruesewitz v. Wyeth LLC
Headline: Court limits lawsuits against vaccine makers by holding federal law pre-empts state design-defect claims, making it harder for families to sue manufacturers over vaccine design-related injuries.
Holding:
- Limits families’ ability to sue vaccine makers over design-related injuries in state court.
- Pushes most vaccine-injury claims into the federal no-fault compensation program instead of state lawsuits.
- Shifts safety and design questions toward federal agencies and reduces state-level incentives to change vaccine design.
Summary
Background
The dispute involves a child who developed seizures after receiving a DTP vaccine and her parents who sought compensation through the federal vaccine program and later sued the vaccine maker in state court claiming the vaccine’s design was defective. The family lost in the federal claims process, rejected that judgment, and then filed state-law claims in Pennsylvania; lower federal courts held those design-defect claims were barred by the National Childhood Vaccine Injury Act, and the Supreme Court agreed to decide the question.
Reasoning
The Court asked whether the Act’s phrase about “side effects that were unavoidable even though the vaccine was properly prepared and accompanied by proper directions and warnings” allows state juries to challenge a vaccine’s design. The majority read the text and the Act’s structure to mean that once a vaccine is properly manufactured and warned, any remaining side effects are treated as unavoidable, so state design-defect claims are pre-empted. The opinion also relied on the statute’s compensation program and federal vaccine oversight as evidence Congress intended to limit design lawsuits. Justice Breyer wrote separately to agree, citing legislative history and agency expertise.
Real world impact
The ruling means people injured by vaccine side effects generally cannot bring state-law claims that attack a vaccine’s design for vaccines covered by the Act; injured parties can seek relief through the federal no-fault program or pursue claims for manufacturing or labeling failures or narrow exceptions. The decision narrows state tort liability and shifts design and safety disputes toward federal agencies and the compensation system.
Dissents or concurrances
Justice Sotomayor dissented, arguing the statute should allow a case-by-case showing that a feasible alternative design existed and warning the ruling removes incentives for safer vaccine design; Justice Breyer concurred, agreeing with the result and stressing legislative history and agency views.
Opinions in this case:
Ask about this case
Ask questions about the entire case, including all opinions (majority, concurrences, dissents).
What was the Court's main decision and reasoning?
How did the dissenting opinions differ from the majority?
What are the practical implications of this ruling?